首页> 外文OA文献 >The phosphoinositide 3-kinase signaling pathway is involved in the control of modified low-density lipoprotein uptake by human macrophages
【2h】

The phosphoinositide 3-kinase signaling pathway is involved in the control of modified low-density lipoprotein uptake by human macrophages

机译:磷酸肌醇3-激酶信号通路参与人类巨噬细胞对修饰的低密度脂蛋白摄取的控制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The transformation of macrophages into lipid-loaded foam cells is a critical early event in the pathogenesis of atherosclerosis. Both receptor-mediated uptake of modified LDL, mediated primarily by scavenger receptors-A (SR-A) and CD36 along with other proteins such as lipoprotein lipase (LPL), and macropinocytosis contribute to macrophage foam cell formation. The signaling pathways that are involved in the control of foam cell formation are not fully understood. In this study, we have investigated the role of phosphoinositide 3-kinase (PI3K) in relation to foam cell formation in human macrophages. The pan PI3K inhibitor LY294002 attenuated the uptake of modified LDL and macropinocytosis, as measured by Lucifer Yellow uptake, by human macrophages. In addition, the expression of SR-A, CD36 and LPL was attenuated by LY294002. The use of isoform-selective PI3K inhibitors showed that PI3K-β, -γ and -δ were all required for the expression of SR-A and CD36 whereas only PI3K-γ was necessary in the case of LPL. These studies reveal a pivotal role of PI3K in the control of macrophage foam cell formation and provide further evidence for their potential as therapeutic target against atherosclerosis.
机译:巨噬细胞向负载脂质的泡沫细胞的转化是动脉粥样硬化发病机理中的关键早期事件。受体介导的主要由清道夫受体-A(SR-A)和CD36以及其他蛋白质(如脂蛋白脂肪酶(LPL))介导的修饰LDL的摄取和巨胞饮作用均有助于巨噬细胞泡沫细胞的形成。尚未完全了解控制泡沫孔形成的信号传导途径。在这项研究中,我们研究了磷酸肌醇3激酶(PI3K)在人类巨噬细胞中泡沫细胞形成方面的作用。潘氏PI3K抑制剂LY294002减弱了人巨噬细胞对修饰的LDL的摄取和巨噬细胞的摄取,这通过荧光素黄摄取测定。另外,LY294002减弱了SR-A,CD36和LPL的表达。使用同工型选择性PI3K抑制剂表明,对于SR-A和CD36的表达,PI3K-β,-γ和-δ都是必需的,而对于LPL,仅PI3K-γ是必需的。这些研究揭示了PI3K在控制巨噬细胞泡沫细胞形成中的关键作用,并为PI3K作为抗动脉粥样硬化的治疗靶标提供了进一步的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号